Decentralized trials (DCTs) allow for a novel, agile and more cost-effective approach to an industry standard and traditional methodology.
Standardized data creates smarter health care and drives innovation and improved outcomes.
PAS continues to spearhead research in understanding outcomes of COVID-19 and its impact on pregnant women, increased risk of myocarditis and healthcare resource utilization.
Detroit-based health system recognized by Premier Inc. for unparalleled innovation and commitment to healthcare transformation.
“We are thrilled that Jessica and Denise will be sharing their experience and knowledge with our board,” said CancerCare CEO Patricia J. Goldsmith.
Investing in a Decentralized Clinical Trial strategy can help improve life sciences companies' resilience and research efforts and deliver strategic returns.
Learn how to use PINC AI™ Healthcare Data to gain in-depth, patient-level, longitudinal real-world data to save money, time and support efficient healthcare decisions.
Henry Ford Innovations and PINC AI Applied Sciences partner to accelerate the research, testing and development of new products, services, interventions and healthcare initiatives.
Top five life science trends that will change the way medical solutions are developed and administered.
Here are three ways life science companies can utilize real-world data and evidence derived from charge master data to provide value and improve outcomes.
Three ways to effectively use real-world-data and real-world evidence to conduct clinical studies, improve drug, device, and diagnostic discovery, and gain regulatory approval.
Understand the new CMS Maternal Morbidity Structural Measure and learn how Premier can help your hospital or health systems answer ‘yes’ to this measure.
Life sciences companies need to invest in RWD/RWE as payers, regulatory bodies, and health systems demand proof that a medical solution delivers real value.
Many diseases are caused by alterations in our genes. By identifying these alterations through genomics, people can gain valuable information about their risk.
Due to globally emerging infectious diseases such as drug-resistant pathogens and the more recent COVID-19 virus, there may be increased risk of exposure to hazards...
A main objective for any life sciences company is to demonstrate the value of their products in improving the lives of patients and ensure...
Real-world evidence can go beyond answering the question of “does this work” and help provide an answer to the more important question of “does this...
How can providers educate patients about their options, overcome patient vaccine hesitancy, reduce racial and ethnic disparities and ensure supply to increase flu vaccination rates?
The quantity of data available to modern healthcare organizations is unprecedented, with more data generated every day. Here’s seven examples of how your organization can…...
A healthcare database that provides the unique opportunity to use real-world data to conduct evidence-based and population-based analyses of drugs, devices, disease states…
How PINC AI™ Applied Sciences, GE and St. Luke’s University Health Network Came Together to Adapt a One-Stop Breast Clinic Model for the United States...
The life sciences industry is fueled by research and innovation, with a focus on developing, teaching, testing and researching care delivery practices and real-world interventions...
This clinical trial will evaluate the value of hospital-wide patient bathing and the impact of specialized protocol training, education and compliance auditing on reducing hospital-acquired...
PIRC aims to assist partners with innovation and to optimize healthcare and its delivery through research and collaborative efforts.
This collaborative aims to investigate outcomes of mothers and babies individually and together, identify social determinants of health and uncover strategies to reduce racial, ethnic...
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
Persistent severe AKI in hospitalized patients can cause adverse outcomes, clinicians are working to identify risks and provide intervention to improve outcomes and reduce costs.
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
Therapeutic Landscape for Treatment of HER2+ mBC Continues to Evolve.
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
Michael J. Alkire, CEO at Premier, said the PINC AI brand will highlight how the firm is accelerating its innovation.
Mike shares his thoughts about the next frontier in healthcare, including Premier's recently launched PINC AI™ platform.
The healthcare technology market today is flooded with ideas but creating meaningful and sustainable change is complex.
A new study conducted via the U.S. Premier Healthcare Database revealed nearly one in every four Covid-19 deaths may be attributed to hospital strain.
See how we're leveraging our rich data sets to uncover new oncology insights.
Premier's Roni Christopher weighs in on the FDA's approval of a Biogen treatment for patients with Alzheimer's disease.
Get a sneak peek at Premier's tools to assess, diagnose and care for patients who may be appropriate candidates for new AD treatments.
Premier Applied Sciences to analyze study results and evaluation of the product aimed at improving outcomes and lowering costs for male urinary disorders.
Natural language processing technology is a promising gamechanger.
Premier Applied Sciences, the research and analytics division of Premier, is putting game-changing NLP technology into the hands of health systems and life sciences companies.
The Premier Healthcare Database has become a frontrunner in COVID-19 research, used by the CDC, the NIH and leading academic institutions.
This paper examines the uptake and accuracy of diagnosis for COVID-19 in U.S. hospitals.
Premier's Ning Rosenthal discusses findings from a recent study that looked at patients with COVID-19 in US acute care hospitals.
GE Healthcare and Premier Applied Sciences® selected St. Luke’s as an ideal pilot site for the One-Stop Clinic breast care model.
Using the Premier Healthcare Database, this study looked at patients with COVID-19 in US acute care hospitals and high ICU admission and in-hospital mortality rates.
At Premier, our members have partnered with us to find truly innovative solutions to the biggest problems facing healthcare and our nation during the pandemic.
This study used a performance platform to enhance clinicians' management of patients with diabetes and osteoporosis.
Finding the right patients and providing a catalyst for change in behavior and treatment has an incredible amount of potenital. Learn how to support care...
Premier's Myla Maloney discusses how health systems and life sciences companies are using data to change COVID-19 care.
Myla Maloney talks about what makes the PHD unique, and how biopharma can leverage data to learn how their drugs perform in the real world.
Join us for A Review of Alzheimer's Disease and Related Conditions Burden of Illness, 2016-2019
Partnership leverages Premier’s dataset and proven methodology to scale advancements in care, driving stronger maternal and infant health outcomes in hospitals across the nation
Learn how Premier’s dynamic stability solutions allow organizations to predict disruptions and use data to adapt to today’s changing and turbulent healthcare environment.
Premier Applied Sciences® has implemented evidence-based care practices with nearly 370 hospitals designed to prevent patients with hyperkalemia from requiring treatment in the acute-care setting.
The Critical Care Medicine Department at the NIH will be granted access to the Premier Healthcare Database to research the impact of COVID-19 on patients.
Every organization is thirsting for data, trajectories and guidance in real time. Leveraging a proven collaborative model is key.
Premier's Leigh Anderson and Denise Juliano discuss the steps life science companies are taking to shorten the time required to bring solutions to market.
With the increasing number of Americans living with Alzheimer’s comes an increased need for care.
Providers should be thinking through how to determine which early treatments are most effective, capture the results of clinical trials and lead through innovation.
This webinar walks through the attributes of the Premier Healthcare Database (PHD) in relation to COVID-19 and provides insights from a frontline physician in NYC.
Download this white paper for a detailed description of the attributes and capabilities of PINC AI™ Healthcare Data in this special release on COVID-19.
From all of us at Premier, thank you to all the frontline healthcare workers. Keep up the fight. Premier is in your corner.
Approximately 97% of hospitals have implemented at least one conservation protocol for PPE, per our latest survey.
Premier data indicates that demand for chloroquine and hydroxychloroquine spiked dramatically between March 1-17.
Check out six guidelines we're recommending in our daily conversations with healthcare providers, governmental agencies and industry stakeholders.
Premier presented insights and data on supplies that are on allocation and in shortage, and recommendations to protect our supply chain.
Premier's Dr. Safo is using her experience in HIV/AIDS medicine to inform Premier’s work on population health.
Developed by the Premier Applied Sciences® team, Premier Healthcare Database Insights is an analytic tool that provides unmatched perspective through dashboards informed from Premier’s substantial...
Its newfound popularity brings hope of a brighter future in successfully treating a variety of diseases, including multiple forms of cancer.
Severe maternal morbidity factors can force women to stay hospital-bound for 70% longer, the analysis found.
Women are more likely to experience an unexpected outcome during delivery and it's adding to hospital costs, according to a new analysis from Premier.
Severe maternal morbidity factors — the most serious type of childbirth complication — offer the greatest opportunity area to standardize care and save significant costs.
Five ways providers can overcome challenges to drive improvements for expecting mothers and newborns.
Premier's Susan DeVore ranked 29th on the list.
Looking at the HIV care model, there were three notable components working together to achieve successful population health management.
This study provided evidence on the effectiveness of a diabetes quality improvement initiative to achieve better patient outcomes by delivering evidence-based care.
When it comes to maternal and infant health, healthcare providers and lawmakers have been flying blind with many lives at stake.
We hear that major legislation may be introduced this week to address drug shortages.
GE Healthcare and Premier are collaborating to develop a same-day breast cancer diagnosis and treatment model.
Premier submitted a statement during the House's hearing on improving maternal health today, released a maternal and infant health trends report last week and more.
Premier's analysis underscores the critical need to better integrate care delivery between the hospital and pre- and post-care services for mothers and their newborns.
Premier conducted a national trend analysis to explore maternal and infant health outcomes in the hospital, at the time of delivery.
The oncology landscape has changed rapidly, but there are innovative ways to keep pace with the change while avoiding pitfalls.
Evidence-based care and precision medicine continue to help the oncology market advance.
We need to better understand and make use of the data that technology has allowed us to grasp.
For more than 30 years, Premier has been at the forefront of the healthcare industry, diligently reinventing the way healthcare is delivered.
Watch this on-demand webinar to learn about the latest trends and real-world examples in preventing sepsis and improving sepsis care.
Denise Juliano, Group Vice President of Life Sciences, discusses the role of Premier Applied Sciences in Healthcare Transformation with Medical Marketing & Media.
CHARLOTTE, N.C. (January 17, 2019) — Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has significantly enhanced its Premier Applied Sciences® research division...
Steve Valentine and Guy Masters: Looking forward, we see several key trends emerging that will affect hospital and physician providers. Expenses will continue to...
CHARLOTTE, N.C. -– A recent Premier Inc. (NASDAQ: PINC) analysis found that total care for patients who experienced an opioid overdose resulted in $1.9...
Have you ever settled onto your couch on a cold winter’s night, well into an enjoyable Netflix binge, but then get a phone call...
Although gaining ground, limited engagement from suppliers and data challenges are the main barriers to more widespread adoption of value-based contracts in the supply chain.
Susan DeVore joined Cheddar TV to discuss the road ahead for healthcare, including implications for healthcare providers.
Premier Inc. has named Denise Juliano the Group Vice President of Life Sciences for its Applied Sciences division.
Today, new market realities are forcing healthcare organizations to evolve with the trends. But one thing that hasn’t changed is what’s behind effective decisions during...
Value-based contracting for medical surgical products and pharmaceuticals has the opportunity to provide big value for both providers and suppliers. Contracting this way requires...
As your leading research and analytics partner, PINC AI™ Applied Sciences can help your organization improve the overall quality, safety and cost-effectiveness of care.